Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Comparative Study of LoKomat® Exoskeleton VS C-Mill® Treadmill for Gait Recovery in Rehabilitation.

NCT07230470 · Universidad Pontificia de Salamanca · Updated 4 May 2026

What is being tested
Lokomat®; C-Mill
For
Stroke
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 65 years. About 40 people. The full rules are on the registry page.
Where
Spain
When
Starts or started 9 Dec 2025, ends 20 June 2026. Registered 17 Nov 2025.
Results
None posted yet.

In the researchers' words

The use of robotic technology for the treatment of gait in neurological pathologies has provided different results in scientific evidence. In patients with some types of acquired brain damage, such as stroke, the use of Lokomat® therapy can bring improvements in aspects such as gait speed and balance, among other parameters and report greater functional recovery in subacute patients with greater deterioration. Similarly, the use of another technological element such as the C-Mill® reports improvements in various aspects of ambulation and balance in gait treatments for stroke patients. Likewise, the impact on the person's recovery is not only beneficial for gait rehabilitation, but also improves the perception of well-being, which can be positive in the process of readaptation to daily life. The effect of both treatments for gait rehabilitation in adults with stroke and their impact on quality of life in the neurorehabilitation clinic will be studied. adults with stroke and their impact on quality of life at the Lescer neurorehabilitation clinic Lescer, Madrid (Spain). Participants will be assessed at baseline, 4 weeks, 8 weeks and 12 weeks.
ClinicalTrials.gov, NCT07230470

Sites

  • Universidad Pontificia de SalamancaSalamanca, Spain